Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Cooperation and sensitivity to social feedback during group interactions in schizophrenia.

Hanssen E, Fett AK, White TP, Caddy C, Reimers S, Shergill SS.

Schizophr Res. 2018 Jul 10. pii: S0920-9964(18)30409-2. doi: 10.1016/j.schres.2018.06.065. [Epub ahead of print]

PMID:
30005931
2.

Long-term follow-up of clozapine prescribing.

Gee SH, Shergill SS, Taylor DM.

J Psychopharmacol. 2018 May;32(5):552-558. doi: 10.1177/0269881118760666. Epub 2018 Apr 25.

PMID:
29692222
3.

Integration is not necessarily at odds with reductionism.

Joyce DW, Shergill SS.

Int J Soc Psychiatry. 2018 Apr 1:20764018770476. doi: 10.1177/0020764018770476. [Epub ahead of print] No abstract available.

PMID:
29638180
4.

Differential neural reward mechanisms in treatment-responsive and treatment-resistant schizophrenia.

Vanes LD, Mouchlianitis E, Collier T, Averbeck BB, Shergill SS.

Psychol Med. 2018 Feb 14:1-10. doi: 10.1017/S0033291718000041. [Epub ahead of print]

PMID:
29439750
5.

Real-time fMRI neurofeedback to down-regulate superior temporal gyrus activity in patients with schizophrenia and auditory hallucinations: a proof-of-concept study.

Orlov ND, Giampietro V, O'Daly O, Lam SL, Barker GJ, Rubia K, McGuire P, Shergill SS, Allen P.

Transl Psychiatry. 2018 Feb 12;8(1):46. doi: 10.1038/s41398-017-0067-5.

6.

White matter changes in treatment refractory schizophrenia: Does cognitive control and myelination matter?

Vanes LD, Mouchlianitis E, Wood TC, Shergill SS.

Neuroimage Clin. 2018 Jan 28;18:186-191. doi: 10.1016/j.nicl.2018.01.010. eCollection 2018.

7.

When the drugs don't work: treatment-resistant schizophrenia, serotonin and serendipity.

Lowe P, Krivoy A, Porffy L, Henriksdottir E, Eromona W, Shergill SS.

Ther Adv Psychopharmacol. 2018 Jan;8(1):63-70. doi: 10.1177/2045125317737003. Epub 2017 Nov 2.

8.

Hope is a therapeutic tool.

Bressan RA, Iacoponi E, Candido de Assis J, Shergill SS.

BMJ. 2017 Dec 13;359:j5469. doi: 10.1136/bmj.j5469. No abstract available.

PMID:
29237595
9.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2017 Dec;211(6):404-405. doi: 10.1192/bjp.211.6.404. No abstract available.

PMID:
29196408
10.

Decreased value-sensitivity in schizophrenia.

Martinelli C, Rigoli F, Dolan RJ, Shergill SS.

Psychiatry Res. 2018 Jan;259:295-301. doi: 10.1016/j.psychres.2017.10.031. Epub 2017 Oct 23.

PMID:
29096335
11.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2017 Nov;211(5):327-328. doi: 10.1192/bjp.211.5.327. No abstract available.

PMID:
29092841
12.

Stimulating thought: a functional MRI study of transcranial direct current stimulation in schizophrenia.

Orlov ND, O'Daly O, Tracy DK, Daniju Y, Hodsoll J, Valdearenas L, Rothwell J, Shergill SS.

Brain. 2017 Sep 1;140(9):2490-2497. doi: 10.1093/brain/awx170.

PMID:
29050384
13.

Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis.

Joy G, Whiskey E, Bolstridge M, Porras-Segovia A, McDonagh TA, Plymen CM, Shergill SS.

J Clin Psychopharmacol. 2017 Dec;37(6):708-712. doi: 10.1097/JCP.0000000000000792.

PMID:
29049078
14.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2017 Oct;211(4):256-257. doi: 10.1192/bjp.211.4.256. No abstract available.

PMID:
28970311
15.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2017 Sep;211(3):186-187. doi: 10.1192/bjp.211.3.186. No abstract available.

PMID:
28864761
16.

Kaleidoscope.

Tracy DK, Joyce DW, Maitra R, Shergill SS.

Br J Psychiatry. 2017 Aug;211(2):124-125. doi: 10.1192/bjp.211.2.124. No abstract available.

PMID:
28765316
17.

Patient attitudes to clozapine initiation.

Gee SH, Shergill SS, Taylor DM.

Int Clin Psychopharmacol. 2017 Nov;32(6):337-342. doi: 10.1097/YIC.0000000000000188.

PMID:
28704228
18.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2017 Jul;211(1):58-59. doi: 10.1192/bjp.211.1.58. No abstract available.

PMID:
28673955
19.

Are we failing clinical trials? A case for strong aggregate outcomes.

Joyce DW, Tracy DK, Shergill SS.

Psychol Med. 2018 Jan;48(2):177-186. doi: 10.1017/S0033291717001726. Epub 2017 Jun 29.

PMID:
28659228
20.

Rapid-onset clozapine-induced loss of glycaemic control: case report.

Porras-Segovia A, Krivoy A, Horowitz M, Thomas G, Bolstridge M, Ion D, Shergill SS.

BJPsych Open. 2017 May 11;3(3):138-140. doi: 10.1192/bjpo.bp.117.004481. eCollection 2017 May.

21.

The value of novelty in schizophrenia.

Martinelli C, Rigoli F, Averbeck B, Shergill SS.

Schizophr Res. 2018 Feb;192:287-293. doi: 10.1016/j.schres.2017.05.007. Epub 2017 May 9.

22.

White matter deficits in schizophrenia are global and don't progress with age.

Kanaan RA, Picchioni MM, McDonald C, Shergill SS, McGuire PK.

Aust N Z J Psychiatry. 2017 Oct;51(10):1020-1031. doi: 10.1177/0004867417700729. Epub 2017 Apr 6.

23.

Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit.

Gee SH, Taylor DM, Shergill SS, Flanagan R, MacCabe JH.

Ther Adv Psychopharmacol. 2017 Feb;7(2):79-83. doi: 10.1177/2045125316677027. Epub 2016 Dec 2.

24.

An fMRI-compatible force measurement system for the evaluation of the neural correlates of step initiation.

de Lima-Pardini AC, de Azevedo Neto RM, Coelho DB, Boffino CC, Shergill SS, de Oliveira Souza C, Brant R, Barbosa ER, Cardoso EF, Teixeira LA, Cohen RG, Horak FB, Amaro E Jr.

Sci Rep. 2017 Feb 23;7:43088. doi: 10.1038/srep43088.

25.

Realising stratified psychiatry using multidimensional signatures and trajectories.

Joyce DW, Kehagia AA, Tracy DK, Proctor J, Shergill SS.

J Transl Med. 2017 Jan 18;15(1):15. doi: 10.1186/s12967-016-1116-1.

26.

Stimulating cognition in schizophrenia: A controlled pilot study of the effects of prefrontal transcranial direct current stimulation upon memory and learning.

Orlov ND, Tracy DK, Joyce D, Patel S, Rodzinka-Pasko J, Dolan H, Hodsoll J, Collier T, Rothwell J, Shergill SS.

Brain Stimul. 2017 May - Jun;10(3):560-566. doi: 10.1016/j.brs.2016.12.013. Epub 2016 Dec 28.

PMID:
28057452
27.

Visual Population Receptive Fields in People with Schizophrenia Have Reduced Inhibitory Surrounds.

Anderson EJ, Tibber MS, Schwarzkopf DS, Shergill SS, Fernandez-Egea E, Rees G, Dakin SC.

J Neurosci. 2017 Feb 8;37(6):1546-1556. doi: 10.1523/JNEUROSCI.3620-15.2016. Epub 2016 Dec 26.

28.

Inflammatory response to clozapine in the absence of myocarditis: case report.

Davey P, Gee S, Shergill SS.

BJPsych Open. 2016 Jun 22;2(3):244-246. eCollection 2016 May.

29.

Self-harm and suicidal acts: a suitable case for treatment of impulsivity-driven behaviour with repetitive transcranial magnetic stimulation (rTMS).

Tracy DK, Shergill SS, David AS, Fonagy P, Zaman R, Downar J, Eliott E, Bhui K.

BJPsych Open. 2015 Sep 2;1(1):87-91. eCollection 2015 Jun. Review.

30.

Reduced susceptibility to the sound-induced flash fusion illusion in schizophrenia.

Vanes LD, White TP, Wigton RL, Joyce D, Collier T, Shergill SS.

Psychiatry Res. 2016 Nov 30;245:58-65. doi: 10.1016/j.psychres.2016.08.016. Epub 2016 Aug 6.

PMID:
27526318
31.

A systematic review of the effects of low-frequency repetitive transcranial magnetic stimulation on cognition.

Lage C, Wiles K, Shergill SS, Tracy DK.

J Neural Transm (Vienna). 2016 Dec;123(12):1479-1490. Epub 2016 Aug 8. Review.

32.

Aberrant Force Processing in Schizophrenia.

Martinelli C, Rigoli F, Shergill SS.

Schizophr Bull. 2017 Mar 1;43(2):417-424. doi: 10.1093/schbul/sbw092.

33.

A Bayesian model of context-sensitive value attribution.

Rigoli F, Friston KJ, Martinelli C, Selaković M, Shergill SS, Dolan RJ.

Elife. 2016 Jun 22;5. pii: e16127. doi: 10.7554/eLife.16127.

34.

White Matter Microstructural Organization Is Higher with Age in Adult Superior Cerebellar Peduncles.

Kanaan RA, Allin M, Picchioni MM, Shergill SS, McGuire PK.

Front Aging Neurosci. 2016 Apr 14;8:71. doi: 10.3389/fnagi.2016.00071. eCollection 2016.

35.

Factors associated with changes in hospitalisation in patients prescribed clozapine.

Gee SH, Shergill SS, Taylor DM.

J Psychopharmacol. 2016 Aug;30(8):819-25. doi: 10.1177/0269881116642745. Epub 2016 Apr 19.

PMID:
27097730
36.

Targeting Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia with fMRI-Based Neurofeedback - Exploring Different Cases of Schizophrenia.

Dyck MS, Mathiak KA, Bergert S, Sarkheil P, Koush Y, Alawi EM, Zvyagintsev M, Gaebler AJ, Shergill SS, Mathiak K.

Front Psychiatry. 2016 Mar 15;7:37. doi: 10.3389/fpsyt.2016.00037. eCollection 2016.

37.

Genome-wide discovered psychosis-risk gene ZNF804A impacts on white matter microstructure in health, schizophrenia and bipolar disorder.

Mallas EJ, Carletti F, Chaddock CA, Woolley J, Picchioni MM, Shergill SS, Kane F, Allin MP, Barker GJ, Prata DP.

PeerJ. 2016 Feb 25;4:e1570. doi: 10.7717/peerj.1570. eCollection 2016.

38.

Learning to trust: trust and attachment in early psychosis.

Fett AK, Shergill SS, Korver-Nieberg N, Yakub F, Gromann PM, Krabbendam L.

Psychol Med. 2016 May;46(7):1437-47. doi: 10.1017/S0033291716000015. Epub 2016 Feb 22.

PMID:
26898947
39.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2016 Feb;208(2):201-2. doi: 10.1192/bjp.208.2.201. No abstract available.

PMID:
26834175
40.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2016 Jan;208(1):98-9. doi: 10.1192/bjp.208.1.98. No abstract available.

PMID:
26729847
41.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2015 Dec;207(6):565-6. doi: 10.1192/bjp.207.6.565. No abstract available.

PMID:
26628703
42.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2015 Nov;207(5):465-6. doi: 10.1192/bjp.207.5.465. No abstract available.

PMID:
26527671
43.

I spy with my little eye - the detection of intentional contingency in early psychosis.

Fett AK, González Berdugo CI, Hanssen E, Lemmers-Jansen I, Shergill SS, Krabbendam L.

Cogn Neuropsychiatry. 2015;20(6):473-81. doi: 10.1080/13546805.2015.1088824. Epub 2015 Oct 14.

PMID:
26465387
44.

Neural correlates of reward processing in healthy siblings of patients with schizophrenia.

Hanssen E, van der Velde J, Gromann PM, Shergill SS, de Haan L, Bruggeman R, Krabbendam L, Aleman A, van Atteveldt N.

Front Hum Neurosci. 2015 Sep 23;9:504. doi: 10.3389/fnhum.2015.00504. eCollection 2015.

45.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2015 Oct;207(4):367-8. doi: 10.1192/bjp.207.4.367. No abstract available.

PMID:
26429693
46.

Dysfunctional Striatal Systems in Treatment-Resistant Schizophrenia.

White TP, Wigton R, Joyce DW, Collier T, Fornito A, Shergill SS.

Neuropsychopharmacology. 2016 Apr;41(5):1274-85. doi: 10.1038/npp.2015.277. Epub 2015 Sep 9.

47.

You looking at me?: Interpreting social cues in schizophrenia.

White TP, Borgan F, Ralley O, Shergill SS.

Psychol Med. 2016 Jan;46(1):149-60. doi: 10.1017/S0033291715001622. Epub 2015 Sep 4.

PMID:
26338032
48.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2015 Sep;207(3):277-8. doi: 10.1192/bjp.207.3.277. No abstract available.

PMID:
26329577
49.

Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment.

Gee S, Dixon T, Docherty M, Shergill SS.

BMC Psychiatry. 2015 Aug 12;15:195. doi: 10.1186/s12888-015-0536-4. Review.

50.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2015 Aug;207(2):183-4. doi: 10.1192/bjp.207.2.183. No abstract available.

PMID:
26243769

Supplemental Content

Loading ...
Support Center